FUS1 (n = 59) | NPRL2/G21 (n = 59) | RASSF1A (n = 59) |
---|---|---|
Median RQ in NSCLC samples | ||
1.35 | 1.36 | 0.77 |
SCC vs AC vs LCC | ||
1.18 vs 1.83 vs 2.39 P = 0.002a | 1.28 vs 1.79 vs 0.83 P = 0.05a | 0.68 vs 1.01 vs 0.86 P = 0.01a |
SCC vs AC | ||
1.18 vs 1.83 P = 0.004b | 1.28 vs 1.84 P = 0.03b | 0.68 vs 1.01 P = 0.002b |
SCC vs NSCC | ||
1.18 vs 2.13 P = 0.001b | P > 0.05 | 0.68 vs 1.01 P = 0.002b |
Age (≤60 yrs vs 61–70 yrs vs >70 yrs) – in total NSCLC group; in NSCLC histopathological subgroups | ||
P > 0.05 | In SCC: 61–70 yrs vs >70 yrs | P > 0.05 |
1.55 vs 0.99 P = 0.001b | ||
Gender (females vs males) – in total NSCLC group; in NSCLC histopathological subgroups | ||
P > 0.05 | P > 0.05 | In SCC: 1.04 vs 0.64 P = 0.02b; |
in AC: 0.86 vs 1.31 P = 0.01b; | ||
in NSCC: 0.86 vs 1.31 P = 0.02b | ||
pTNM classification (T1 vs T2 vs T3/4) – in total NSCLC group; in NSCLC histopathological subgroups | ||
P > 0.05 | P > 0.05 | 0.80 vs 0.67 vs 0.94 P = 0.04a; |
T2 vs T3/4 P = 0.01b; | ||
in NSCC: 1.35 vs 0.75 vs 1.27 P = 0.04a; T2 vs T3/4 P = 0.04b | ||
AJCC classification (I vs II vs III) – in total NSCLC group; in NSCLC histopathological subgroups | ||
In NSCC: 2.44 vs 1.20 vs 2.25 P = 0.04a; I vs II P = 0.02b | P > 0.05 | P > 0.05 |
Smoking status (current smokers vs former smokers vs never smokers) – in total NSCLC group; in NSCLC histopathological subgroups | ||
P > 0.05 | P > 0.05 | P > 0.05 |
Smoking history (PYs: <40 vs ≥40) – in total NSCLC group; in NSCLC histopathological subgroups | ||
P > 0.05 | P > 0.05 | P > 0.05 |
Tumor (T) tissue vs macroscopically unchanged lung tissue – in total NSCLC group; in NSCLC histopathological subgroups | ||
in AC: 1.83 vs 1.18 P = 0.01b; | 1.36 vs 0.84 P = 0.0003b; | 0.77 vs 1.07 P = 0.0003b; |
in NSCC: 2.13 vs 1.20 P = 0.002b | in SCC: 1.28 vs 0.84 P = 0.01b; | in SCC: 0.68 vs 1.09 P = 0.000002b |
in AC: 1.84 vs 0.84 P = 0.002b; | ||
in NSCC: 1.79 vs 0.84 P = 0.009b |